Table 2.
Variable | Unit | EG (n = 16) | PAM (n = 16) | Effect size (η2) | ||
---|---|---|---|---|---|---|
Mean ± SD | (95% CI) | Mean ± SD | (95% CI) | |||
25(OH)D3 | ng/ml | 20.85 ± 3.93 | (18.57–23.12) | 23.17 ± 3.76 | (21.23–25.10) | 0.08 |
24,25(OH)2D3 | ng/ml | 1.38 ± 0.66 | (1.00–1.77) | 1.67 ± 0.84 | (1.24–2.11) | 0.03 |
25(OH)D3 / 24,25(OH)2D3 | ng/ml | 16.79 ± 4.41 | (14.24–19.34) | 15.40 ± 3.65 | (13.52–17.27) | 0.04 |
Procalcitonin | ng/ml | 0.44 ± 0.17 | (0.34–0.54) | 0.27 ± 0.15* | (0.19–0.34) | 0.23 |
C-terminal telopeptide of type I collagen | μg/l | 0.52 ± 0.23 | (0.37–0.63) | 0.36 ± 0.28 | (0.21–0.51) | 0.07 |
N-terminal propeptide of type I collagen | μg/l | 118.50 ± 43.15 | (92.16–144.83) | 140.05 ± 41.45 | (117.05–163.04) | 0.07 |
*Significant difference between gymnasts and controls at p < 0.01